Cancers of unknown primary diagnosed during hospitalization: a population-based study

被引:28
作者
Jones, William [1 ]
Allardice, Gwen [2 ]
Scott, Iona [2 ]
Oien, Karin [1 ]
Brewster, David [3 ]
Morrison, David S. [1 ]
机构
[1] Univ Glasgow, 1 Lilybank Gardens, Glasgow G12 8RZ, Lanark, Scotland
[2] NHS Greater Glasgow & Clyde, Glasgow, Lanark, Scotland
[3] Scottish Canc Registry, Edinburgh, Midlothian, Scotland
关键词
Occult primary neoplasms; Unknown primary tumor; PRIMARY SITE; SURVIVAL; TRENDS;
D O I
10.1186/s12885-017-3083-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Cancers of Unknown Primary (CUP) are the 3-4th most common causes of cancer death and recent clinical guidelines recommend that patients should be directed to a team dedicated to their care. Our aim was to inform the care of patients diagnosed with CUP during hospital admission. Methods: Descriptive study using hospital admissions (Scottish Morbidity Record 01) linked to cancer registrations (ICD-10 C77-80) and death records from 1998 to 2011 in West of Scotland, UK ( population 2.4 m). Cox proportional hazards models were used to assess effects of baseline variables on survival. Results: Seven thousand five hundred ninety nine patients were diagnosed with CUP over the study period, 54.4% female, 67.4% aged >= 70 years, 36.7% from the most deprived socio-economic quintile. 71% of all diagnoses were made during a hospital admission, among which 88.6% were emergency presentations and the majority (56.3%) were admitted to general medicine. Median length of stay was 15 days and median survival after admission 33 days. Non-specific morphology, emergency admission, age over 60 years, male sex and admission to geriatric medicine were all associated with poorer survival in adjusted analysis. Conclusions: Patients with a diagnosis of CUP are usually diagnosed during unplanned hospital admissions and have very poor survival. To ensure that patients with CUP are quickly identified and directed to optimal care, increased surveillance and rapid referral pathways will be required.
引用
收藏
页数:7
相关论文
共 14 条
[1]   Descriptive epidemiology of cancer of unknown primary site in Scotland, 1961-2010 [J].
Brewster, David H. ;
Lang, Jaroslaw ;
Bhatti, Lesley A. ;
Thomson, Catherine S. ;
Oien, Karin A. .
CANCER EPIDEMIOLOGY, 2014, 38 (03) :227-234
[2]  
Cancer Research UK and National Cancer Intelligence Network, 2013, CANC UNKN PRIM NCIN
[3]   Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [J].
Fizazi, K. ;
Greco, F. A. ;
Pavlidis, N. ;
Pentheroudakis, G. .
ANNALS OF ONCOLOGY, 2011, 22 :vi64-vi68
[4]  
Fritz A., 2013, INT CLASSIFICATION D
[5]  
Greco F Anthony, 2012, Clin Adv Hematol Oncol, V10, P518
[6]   Familial Risks in Cancer of Unknown Primary: Tracking the Primary Sites [J].
Hemminki, Kari ;
Ji, Jianguang ;
Sundquist, Jan ;
Shu, Xiaochen .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04) :435-440
[7]   Exploring the epidemiological characteristics of cancers of unknown primary site in an Australian population: implications for research and clinical care [J].
Luke, Colin ;
Koczwara, Bogda ;
Karapetis, Christos ;
Pittman, Ken ;
Price, Tim ;
Kotasek, Dusan ;
Beckmann, Kerri ;
Brown, Michael P. ;
Roder, David .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH, 2008, 32 (04) :383-389
[8]  
National Cancer Intelligence Network, 2014, ROUT DIAGN CANC UNKN
[9]  
National Institute for Health and Clinical Excellence, 2010, MET MAL DIS UNKN PRI
[10]   Cancer of unknown primary site: 20 questions to be answered [J].
Pavlidis, N. ;
Pentheroudakis, G. .
ANNALS OF ONCOLOGY, 2010, 21 :303-307